CCG is hosting a 1-day meeting focusing on benefits of computer-aided ligand and structure-based drug design techniques for medicinal chemists.
Short hands-on workshops in the morning will be followed by scientific presentations in the afternoon. The meeting will end with a social reception.
Please note that space is limited so early registration is recommended.
|08:00-08:30||Morning Coffee and Registration|
Pharmacophore Modeling / Docking / Fragment-based Design / Scaffold Replacement / R-Group Screening / Project Search / Protein-Ligand Interaction Fingerprints
presented by Lewis Vidler, Senior Research Scientist, Eli Lilly
R-Group Profiles and Analysis / MOEsaic / MMP Analysis / Descriptor Calculations / Conformational Searching / Molecular Alignments / Pharmacophore Modeling and Searching / Diversity Analysis
|12:45-13:10||Registration (check-in and badge pick-up)|
|CHAIR: Graeme Robb, AstraZeneca|
Georgia McGaughey, Senior Director, Vertex Pharmaceuticals
Ijen Chen, Principal Scientist, Vernalis plc
Richard Lonsdale, Computational Chemist, GlaxoSmithKline
Andrew Henry, Principal Scientist, Chemical Computing Group
|CHAIR: Markus Kossner, Chemical Computing Group|
Graeme Robb, Senior Computational Chemist, AstraZeneca
Michelle Southey, Computational Chemist, Evotec
Arnout Voet, Assistant Professor, Katholieke Universiteit Leuven
Nick Barton, Scientific Leader, GlaxoSmithKline
There is no cost to attend but pre-registration is required as seats are limited. Registrations will be processed and accepted on a first-come, first-serve basis.